OrbiMed Royalty & Credit Opportunities Access Fund V LP

CIK 2038551 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for OrbiMed Royalty & Credit Opportunities Access Fund V LP.

Recent SEC filings

FiledFormAccession number
Mar 19, 2026D/A0002038551-26-000001
Mar 19, 2025D/A0002038551-25-000001
Sep 30, 2024D0002038551-24-000001